Tonix Pharma's market cap is currently $170.85M. The company's EPS TTM is $-3.86; its P/E ratio is ―; Tonix Pharma is scheduled to report earnings on August 11, 2025, and the estimated EPS forecast is $-3.58. See an overview of income statement, balance sheet, and cash flow financials.
